Header Logo

Mehrian Jafarizade

Concepts (69)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Interleukin-27
1
2021
7
0.690
 Why?
Atherosclerosis
3
2021
163
0.670
 Why?
Venous Thromboembolism
3
2019
150
0.380
 Why?
Benzamides
2
2019
69
0.280
 Why?
Pyridines
2
2019
119
0.270
 Why?
Fibrinolytic Agents
2
2019
178
0.260
 Why?
Percutaneous Coronary Intervention
2
2020
225
0.230
 Why?
Coronary Artery Disease
2
2020
324
0.230
 Why?
Enoxaparin
2
2019
19
0.180
 Why?
Coronary Vessels
2
2020
125
0.180
 Why?
Coronary Vessel Anomalies
2
2020
23
0.180
 Why?
Factor Xa Inhibitors
2
2019
38
0.180
 Why?
Vascular Diseases
2
2020
83
0.170
 Why?
Interleukins
1
2021
87
0.170
 Why?
NLR Family, Pyrin Domain-Containing 3 Protein
1
2021
263
0.150
 Why?
Pre-Exposure Prophylaxis
1
2019
16
0.150
 Why?
Eosinophils
1
2018
49
0.140
 Why?
Inflammasomes
1
2021
352
0.130
 Why?
Cardiology
1
2019
170
0.130
 Why?
Cardiac Catheterization
1
2019
293
0.120
 Why?
Hemorrhage
4
2019
285
0.120
 Why?
Anti-Inflammatory Agents
1
2018
166
0.120
 Why?
Inpatients
1
2019
318
0.120
 Why?
Acute Coronary Syndrome
1
2018
253
0.110
 Why?
Time Factors
2
2019
3762
0.110
 Why?
Risk Factors
5
2020
5422
0.090
 Why?
Inflammation
1
2018
1187
0.090
 Why?
Hospitalization
1
2019
1392
0.090
 Why?
Anticoagulants
3
2019
525
0.080
 Why?
Atrial Fibrillation
1
2018
872
0.070
 Why?
Coronary Angiography
2
2020
212
0.070
 Why?
Humans
8
2021
65095
0.060
 Why?
Stents
2
2020
498
0.060
 Why?
Randomized Controlled Trials as Topic
2
2019
804
0.050
 Why?
Fibromuscular Dysplasia
1
2020
7
0.040
 Why?
Connective Tissue Diseases
1
2020
11
0.040
 Why?
Incidental Findings
1
2020
51
0.040
 Why?
Stress, Mechanical
1
2020
116
0.040
 Why?
Sex Distribution
1
2020
252
0.040
 Why?
Age Distribution
1
2020
262
0.040
 Why?
Myocardial Ischemia
1
2020
118
0.040
 Why?
Takotsubo Cardiomyopathy
1
2020
70
0.040
 Why?
Capillaries
1
2018
32
0.040
 Why?
Drug Administration Schedule
1
2019
296
0.030
 Why?
Clinical Decision-Making
1
2019
169
0.030
 Why?
Cardiovascular System
1
2018
41
0.030
 Why?
Warfarin
1
2018
125
0.030
 Why?
Aspirin
1
2018
172
0.030
 Why?
Recurrence
1
2018
656
0.030
 Why?
Drug Therapy, Combination
1
2018
463
0.030
 Why?
Arrhythmias, Cardiac
1
2018
162
0.030
 Why?
Interleukin-1beta
1
2018
274
0.030
 Why?
Models, Theoretical
1
2018
274
0.030
 Why?
Platelet Aggregation Inhibitors
1
2018
235
0.030
 Why?
Critical Illness
1
2019
329
0.030
 Why?
Registries
1
2019
913
0.030
 Why?
Comorbidity
1
2018
1119
0.030
 Why?
Hypertension
1
2020
612
0.030
 Why?
Risk Assessment
1
2019
2096
0.020
 Why?
Myocardial Infarction
1
2018
919
0.020
 Why?
Adult
2
2019
17351
0.020
 Why?
Middle Aged
2
2019
18254
0.020
 Why?
Aged, 80 and over
1
2019
5606
0.020
 Why?
Stroke
1
2018
1209
0.020
 Why?
Young Adult
1
2018
4810
0.020
 Why?
Treatment Outcome
1
2019
5784
0.020
 Why?
Male
2
2019
31014
0.020
 Why?
Female
2
2019
33997
0.020
 Why?
Aged
1
2019
14945
0.010
 Why?
Jafarizade's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (69)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_